Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

NCT01644565 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

FED

Sponsor class

Conditions

Escherichia Coli Infection

Interventions

BIOLOGICAL: Recombinant fimbrial adhesin dsc14CfaE-sCTA2/LTB5
BIOLOGICAL: Recombinant fimbrial adhesin dscCfaE
BIOLOGICAL: Modified E. coli heat labile enterotoxin LTR192G

Sponsor

U.S. Army Medical Research and Development Command